MRI/Ultrasound Fusion Guided Prostate Cryotherapy
NCT02381990
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Registration of Prostate Cancer patients undergoing Prostate Cryotherapy guided by Mutiparametric-MRI (MP-MRI) highlighting biopsy confirmed regions. The primary outcome measure is 5 year oncological control. Secondary aim is lack of progression beyond the prostate gland. The aim of intervention is to eradicate prostate cancer disease in the treated area while imposing no or minimal deleterious effects in quality of life.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Neoplasms Prostate
- Cancer of the Prostate
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 55 years and older
- Sex
- Male
- Healthy volunteers
- Not accepted
- Sponsor
- Urological Research Network, LLC
- Last updated on ClinicalTrials.gov
- January 26, 2023
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- Urological Research Network · Miami Lakes, FL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.